Dynamic Contrast-Enhanced Magnetic Resonance Imaging Predicts Immediate Therapeutic Response of Magnetic Resonance-Guided High-Intensity Focused Ultrasound Ablation of Symptomatic Uterine Fibroids

Authors:
  • HLHyo K. Lim
    Hyo K. Lim
  • JKJae-Hun Kim
    Jae-Hun Kim
  • HRHyunchul Rhim
    Hyunchul Rhim
  • BPByung Kwan Park
    Byung Kwan Park
  • BKBilgin Keserci
    Bilgin Keserci
  • MKMax O. Köhler
    Max O. Köhler
  • DBDuk-Soo Bae
    Duk-Soo Bae
  • BKByoung-Gie Kim
    Byoung-Gie Kim
  • SSShunmugavelu Sokka
    Shunmugavelu Sokka

Abstract
To evaluate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in the prediction of the immediate therapeutic response of MR-guided high-intensity focused ultrasound (HIFU) therapy in the treatment of symptomatic uterine fibroids Institutional review board approved this study, and informed consent was obtained from all participants. A total of 10 symptomatic uterine fibroids (diameter: mean, 8.9 cm; range, 4.7–12 cm) in 10 female patients (mean age, 42.2 years) were treated with MR-HIFU therapy using the volumetric ablation technique. DCE-MRI and conventional contrast-enhanced MRI were obtained as a baseline and as an immediate follow-up study, respectively. After regions of interest of each treatment cell were properly registered to both MRI studies, DCE-MRI parameters (Ktrans, ve, vp) and operator-controllable therapy parameters (power, treatment cell size, sonication depth) were investigated on a cell-by-cell basis to reflect tissue inhomogeneity. Two types of ablation efficacy indices (volume of 240 equivalent minutes at 43°C/treatment-cell volume, nonperfused volume/treatment-cell volume) were then correlated with those parameters using multiple linear regression analysis to determine which factors were significant predictors for ablation efficacy. We used 293 treatment cells (4 mm, n = 12; 8 mm, n = 115; 12 mm, n = 149; 16 mm, n = 17), and all of them were analyzable. Ablation efficacies were 1.06 ± 0.58 and 0.67 ± 0.39. Ktrans (B = −12.035, P Conclusions: A higher Ktrans value at baseline DCE-MRI suggested a poor ablation efficacy of MR-HIFU therapy for symptomatic uterine fibroids.

This publication has 32 references indexed in Scilit: